[HTML][HTML] Pharmacological modulation of vascular ageing: a review from VascAgeNet
Vascular ageing, characterized by structural and functional changes in blood vessels of
which arterial stiffness and endothelial dysfunction are key components, is associated with …
which arterial stiffness and endothelial dysfunction are key components, is associated with …
Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases
A Molaei, E Molaei, AW Hayes, G Karimi - Cell Cycle, 2023 - Taylor & Francis
MasR is a critical element in the RAS accessory pathway that protects the heart against
myocardial infarction, ischemia-reperfusion injury, and pathological remodeling by …
myocardial infarction, ischemia-reperfusion injury, and pathological remodeling by …
Cardiovascular outcomes in the acute phase of COVID-19
H Nakano, K Shiina, H Tomiyama - International Journal of Molecular …, 2021 - mdpi.com
The cumulative number of cases in the current global coronavirus disease 19 (COVID-19)
pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS …
pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS …
Enalapril is superior to lisinopril in improving endothelial function without a difference in blood–pressure–lowering effects in newly diagnosed hypertensives
Angiotensin–converting enzyme (ACE) inhibitors are the primarily chosen drugs to treat
various cardiovascular diseases, such as hypertension. Although the most recent guidelines …
various cardiovascular diseases, such as hypertension. Although the most recent guidelines …
Research progress in the mechanism of Ang（ 1-7） on cardiac remodeling in hypertensive patients
MA Quanping, Y Jinlong, Y Zhen - J Clin Cardiol, 2021 - en.whuhzzs.com
Hypertension is the most common risk factor for cardiovascular disease and can promote
cause ventricular hypertrophy and heart failure through various mechanisms. Among them …
cause ventricular hypertrophy and heart failure through various mechanisms. Among them …